“R.itemList.length” “- this.config.text.ariaShown
“This.config.text.ariaFermé”
Early laboratory effects help registered genetics have an ik-nik effect on the SARS-CoV-2 replication cycle
BOGOT, Colombia, August 26, 2020 / PRNewswire / – Ik-nik Farms, Pideka SAS (“Pideka”) is pleased to announce the effects of its COVID-19 exam conducted through an external laboratory that uses agronomically grown genetics at “Casa Flores”, the hash camp in Pideka, Colombia.
“We are pleased to announce the effects of our COVID-19 and the positive implications for the virus replication cycle,” said Brian Baca, CEO of Ik-nik Farms.
The corporate gave to the immunovirology organization of the University of Antioquia (“UdeA”) samples of several qualified strains grown agronomically in Casa Flores. Research conducted through “UdeA” and concluded that the strains inhibited up to 62.5% of SARS-CoV-2.
Test
The tests were performed through the UdeA immunovirology organization in its A1 Biosafe laboratory to determine the antiviral activity of cannabinoids and the remote SARS-VoC-2 virus. The University conducted two experiment teams, using the foreign method used for the antiviral effect of compounds for SARS-CoV-2 mitigation.
In the first organization of experiments, it was decided the optimal dose of derivatives in which the feasibility of healthy cells grown in the VERO E6 culture medium was decided to overcome the criterion of foreign acceptance of 20% cytotoxicity, the experiment with cannabis-based products, sought a general cellular viability 10% per cent.
At the time of the organization of the experiments, the antiviral activity of hash derivatives on the SARS-CoV-2 virus was established, applying the preventive and optimal dose of the products received in cytotoxicity experiments. Negative and positive controls have been implemented to correct the ANTIVIRAL effect of hash derivatives using sheet metal controls. The viral name SARS-CoV-2 was decided after hashish treatment, measuring the relief resulting from hashish derivatives. The name received was 4.2 x 106 UFP (plate formation units) / ml. A microbiological check of the samples provided was also carried out that did not show the presence of pathogenic fungi or bacteria, which is a requirement established through the European Pharmacopoeia, the European legal and clinical reference for pharmacopoeia standards.
“We are very happy to work with the UdeA, as the first educational establishment in Colombia to isolate the virus. We will continue our studies abroad in the hope of finding a viable cannabinoid for the existing global crisis,” said Borja Sanz of Madrid. President of Ik-nik International.
About University of Antioquia
The University of Antioquia is a public university founded in 1803. Its main campus is located in the city of Medellin, Colombia; In addition, it has other campuses and amenities in the nine regions of the branch of Antioquia, Colombia. The aim of the University of Antioquia is to pursue, expand and disseminate wisdom in the humanities, sciences, arts, philosophy and generation through research, coaching and outreach activities. The university is composed of 25 educational sets divided into 14 faculties, 4 schools, 4 institutes and 3 societies that in combination offer about 130 undergraduate systems. In addition, 58 specializations, 46 medical specialties, 57 master’s systems and 23 doctoral systems will be offered for a total of 184 postgraduate systems.
About Ik-nik Farms
Ikanik Farms creates a dynamic portfolio of hash brands for global pharmaceutical demand, rooted in fitness and wellness, action sports and unified with passion. The company’s leadership brings decades of experience in studies and development, culture, retail, branding and corporate finance with the ambition to build the multinational operator “seed-to-sale”, “MNO”, the world’s flagship, vertically incorporated. Lately it has operations in California and Colombia through its pharmaceutical division Pideka, which has the certifications GMP_PHARMA and (GACP) Good agricultural and collection practices for the operating site Casa Flores.
Link related to Corporate – www.iknkbrands.com Pideka Site – www.pidekagroup.com Brand Site – www.ikanikfarms.com
Forward-looking statements
This press release includes “forward-looking information” and “forward-looking statements” within the meaning of Canadian securities law and U.S. securities law (Collectively, “Forward-Looking Information”). All information, other than statements of old facts, included in this press release dealing with activities, occasions or advances that the Company anticipates or anticipates will happen or possibly happen in the long term, are forward-looking information. When used in this press release, words such as “will,” “could,” “plan,” “estimate,” “expect,” “possibly,” “potential,” “believe,” “should” and similar expressions, are forward-looking information, including, but not limited to, statements regarding the effectiveness of the COVID-19 remedy with pharmaceutical-grade hash oil or any other hashish product.
While the Company has attempted to identify vital points that may also cause actual results, functionality, or achievements to differ materially from the content in prospective information, there may be other points that cause results, functionality, or achievements to fail to be met. expectations or estimates. or planned, including, but not limited to: cannabis-based products with no medical advantages in the COVID-19 remedy, the allocation cannot be completed within the time frame described here, or at all, adjustments in the legislation, a replacement in the administration, inability to download more funds, increased competition, obstacle to market expansion and government adoption due to public opinion and incoherent belief in the medical marijuana industry and for adults and regulatory or political adjustments.
There can be no guarantee that this data will prove to be accurate or that management expectations or estimates related to long-term developments, cases or effects will materialize. As a result of these hazards and uncertainties, the expected effects or occasions on prospective data may differ materially from actual effects or occasions.
As a result, readers deserve not to place undue reliance on forward-looking data. The prospective data contained in this press release is provided as of the date of this press release. The Company waives any legal purpose or duty to update or revise this data, as required by applicable law, and the Company assumes no disclosure duty of any other company mentioned herein.
On behalf of the Board of Directors of Ik-nik Farms, Inc.
View the content to download multimedia: http://www.prnewswire.com/news-releases/ikanik-farms-completes-in-vitro-covid-19-study-with-independent-laboratory—shows-potential-for- treatment-future-cannabinoide-del-coronavirus-301118867.html
SOURCE Ikanik Farms Inc.